Skip to main content


Study: Statins linked to lower cancer deaths

Those who used cholesterol-lowering drugs originally had lower cancer risk

A study conducted in Denmark found an association between the use of statins and a decreased risk of death from cancer or all-cause mortality. The study enrolled all patients with cancer in Denmark from 1995 to 2007. Researchers then compared mortality rates among those who were taking statins at the time of the cancer diagnosis to those who were not taking statins.

Lipitor is among the most common of commercially available statins, intended to lower cholesterol levels.

Lipitor is among the most common of commercially available statins, intended to lower cholesterol levels.

LOS ANGELES, CA (Catholic Online) - Statin use is generally associated with a lower risk of dying from cancer for those patients who used the cholesterol-lowering drugs before their cancer diagnosis.

Statin users in Denmark had a 15 percent reduction in the risk of cancer mortality compared with those who had not used the drugs.

According to Stig Bojesen, MD, PhD, of the Copenhagen University Hospital in Denmark, the study revealed that statin users had a similar reduction in the risk of all-cause mortality. Reporting in the Nov. 8 issue of the New England Journal of Medicine, Bojesen and colleagues suggest "a need for trials of statins in patients with cancer."

Bojesen and his colleagues noted that despite the fact that trials of the drugs to reduce cardiovascular disease have not shown any reduction either in cancer incidence or mortality, there is evidence that the biochemical pathways involved in cancer growth and spread can be affected by statins.

The databases included the study of statin prescriptions, cancer diagnoses and mortality.

All told, among cancer patients 40 and older, 18,721 had used statins regularly before the diagnosis and 277,204 had never been given the drugs, they reported.

During 1,072,503 person-years of follow-up, 162,067 patients died of cancer, 14,489 of cardiovascular causes, and 19,038 of other causes.

Overall the analysis showed that:

-- The cumulative incidence of death from cancer, as a function of follow-up time, was significantly lower among statin users than among patients who had never used statins, with a log-rank P<0.001.

-- The multivariable hazard ratio was 0.85, with a 95 percent confidence interval from 0.82 to 0.87.

-- The cumulative incidence of death from any cause was also lower, with a log-rank P<0.001.

-- The multivariable hazard ratio was 0.85, with 95 percent confidence interval from 0.83 to 0.87.

However, Bojesen cautioned that among other things, the study was based on the mostly white population of Denmark, but may not apply more widely.

© 2012, Catholic Online. Distributed by NEWS CONSORTIUM.

- - -

Pope Benedict XVI's Prayer Intentions for January 2013
General Intention:
The Faith of Christians. That in this Year of Faith Christians may deepen their knowledge of the mystery of Christ and witness joyfully to the gift of faith in him.
Missionary Intention: Middle Eastern Christians. That the Christian communities of the Middle East, often discriminated against, may receive from the Holy Spirit the strength of fidelity and perseverance.

Keywords: Statins, lipitor, cancer risk, Denmark, research

NEWSLETTERS »

E-mail:       Zip Code: (ex. 90001)
Today's Headlines

Sign up for a roundup of the day's top stories. 5 days / week. See Sample

Rate This Article

Very Helpful Somewhat Helpful Not Helpful at All

Yes, I am Interested No, I am not Interested

Rate Article

0 Comments

Leave a Comment

Comments submitted must be civil, remain on-topic and not violate any laws including copyright. We reserve the right to delete any comments which are abusive, inappropriate or not constructive to the discussion.

Though we invite robust discussion, we reserve the right to not publish any comment which denigrates the human person, undermines marriage and the family, or advocates for positions which openly oppose the teaching of the Catholic Church.

This is a supervised forum and the Editors of Catholic Online retain the right to direct it.

We also reserve the right to block any commenter for repeated violations. Your email address is required to post, but it will not be published on the site.

We ask that you NOT post your comment more than once. Catholic Online is growing and our ability to review all comments sometimes results in a delay in their publication.

Send me important information from Catholic Online and it's partners. See Sample

Post Comment


Newsletter Sign Up